🧫 Experiment Protocol
ExploratorycancerNPM1OVA-presenting tumor cells and OT-1 transgenic T cellsproposed
Assessment of antigen-specific T-cell mediated killing of tumor cells presenting ovalbumin (OVA) by OT-1 transgenic T cells. This experiment evaluated how NPM1 deficiency affects the ability of tumor cells to present antigens and be recognized and killed by specific cytotoxic T lymphocytes. The study demonstrated that Npm1 deficiency increased MHC-I and MHC-II molecule expression and enhanced specific T-cell killing capacity.
PRIMARY OUTCOME
T-cell mediated tumor cell killing efficiency
EXPECTED OUTCOMES
NPM1 deficiency would enhance T-cell recognition and killing of tumor cells
SUCCESS CRITERIA
Increased cytotoxic T lymphocyte-mediated tumor cell death
PROTOCOL
In vitro co-culture of OVA-presenting tumor cells with OT-1 transgenic T cells to measure antigen-specific cytotoxicity